Recent Finacing
Recent Raise
Laguna Pharmaceuticals (formerly ChanRx) develops vanoxerine, an IV antiarrhythmic advancing from Phase 2b to Phase 3 for restoration of normal sinus rhythm in atrial fibrillation and flutter.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors